Marc E. Lippman - 14 May 2021 Form 4 Insider Report for Seagen Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 14 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2021, 19:29:12 UTC
Next SEC filing: 23 Mar 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Elizabeth Bekiroglu For: Marc E. Lippman

Key filing fact

Marc E. Lippman filed Form 4 for Seagen Inc. on 18 May 2021.

Key facts

This page summarizes Marc E. Lippman's Form 4 filing for Seagen Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 May 2021, 19:29.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGEN transaction

Common Stock

Award

Transaction value: $0
Shares: +1,402
Change %: +2.7%
Price: $0.000000
Shares after: 53,740
Date: 14 May 2021
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGEN transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +3,462
Change %
Price: $0.000000
Shares after: 3,462
Date: 14 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,462
Exercise price: $147.50

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These restricted stock units will be settled in common stock upon vesting.

Footnote F2

These restricted stock units shall vest in full on May 14, 2022.

Footnote F3

Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .